Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016
Panacea Biotec Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Disclosure of Voting results of EGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Panacea Biotec Ltd has informed BSE regarding the details of Voting results at the Extra Ordinary General Meeting (EGM) of the Company held on March 30, 2016, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Outcome of EGM
Panacea Biotec Ltd has informed BSE that the Extra Ordinary General Meeting (EGM) of the Company was held on March 30, 2016. Panacea Biotec Receives Prestigious Intellectual Property & Science Award "Top 50 Indian Innovators 2015"
Panacea Biotec Ltd has informed BSE regarding a Press Release dated March 30, 2016 titled "Panacea Biotec Receives Prestigious Intellectual Property & Science Award "Top 50 Indian Innovators 2015"". Panacea Biotec Launches - CABAPAN, A Cost Effective product for the treatment of metastatic Castration Resistant Prostrate Cancer (mCRPC)
Panacea Biotec Ltd has informed BSE regarding a Press Release dated March 28, 2016 titled "Panacea Biotec Launches - CABAPAN, A Cost Effective product for the treatment of metastatic Castration Resistant Prostrate Cancer (mCRPC)". Credit Rating
Panacea Biotec Ltd has informed BSE regarding "Credit Rating for Long Term bank facilities of Rs.1202.88 cr. and Short term bank facilities of Rs. 61.97 cr." Newspaper advertisements for Notice of EGM
Panacea Biotec Ltd has submitted to BSE a copy of the newspaper advertisements, containing, inter-alia, Notice of EGM, Remote E-voting information and cut-off date, published in the newspapers. EGM on March 30, 2016
Panacea Biotec Ltd has informed BSE that the Extra Ordinary General Meeting (EGM) of the Company will be held on March 30, 2016. Circular resolution by Board of Directors (EGM on March 30, 2016)
Panacea Biotec Ltd has informed BSE that the Board of Directors of the Company had, vide resolution passed by circulation on February 29, 2016, decided that an Extra-ordinary General Meeting of the Company will be held on March 30, 2016 at 11:30 a.m. at the Registered Office of the Company at Ambala-Chandigarh Highway, Lalru - 140501, Punjab. Outcome of Board Meeting
Panacea Biotec Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 12, 2016, appointed the following persons as directors on the Board of Directors of the Company to be effective from April 01, 2016:1. Mr. Mukul Gupta, as a non-executive independent director of the Company, and2. Mr. Ankesh Jain, as a Whole-time Director (designated as Director Sales & Marketing) and Key Managerial Personnel of the Company.